Free Design Audit Available - Click Here for Details

FDA Clears Clarius OB AI for Handheld Ultrasound: A Leap Forward in Prenatal Care

The company's 8th AI model makes ultrasound easier for new ultrasound users to capture important fetal measurements

VANCOUVER, BC, June 25, 2024 /PRNewswire/ — Clarius Mobile Health, a leading provider of high-definition handheld ultrasound systems, has obtained FDA clearance for the Clarius OB AI fetal biometric measurement tool, improving access to obstetrical (OB) prenatal monitoring and care in resource-limited areas. The OB AI model automatically performs fetal biometry measurements to estimate fetal age, weight and growth intervals and is available now with the Clarius C3 HD3 wireless handheld ultrasound scanner in the United States and Canada.

Developed with state-of-the-art deep learning models leveraging more than 30,000 de-identified fetal ultrasound images, Clarius OB AI provides consistent and precise measurements enabling new ultrasound users, including midwives and nurses, the ability to perform accurate fetal ultrasound measurements with confidence.

Sign up for Blog Updates